93 related articles for article (PubMed ID: 20061290)
1. How much do I give? Reevaluation of insulin dosing estimation formulas using continuous glucose monitoring.
King AB
Endocr Pract; 2010; 16(3):428-32. PubMed ID: 20061290
[TBL] [Abstract][Full Text] [Related]
2. How much do I give? Dose estimation formulas for once-nightly insulin glargine and premeal insulin lispro in type 1 diabetes mellitus.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(3):382-6. PubMed ID: 22440988
[TBL] [Abstract][Full Text] [Related]
3. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing.
King AB; Armstrong DU
J Diabetes Sci Technol; 2007 Jan; 1(1):42-6. PubMed ID: 19888378
[TBL] [Abstract][Full Text] [Related]
4. The number of basal rates required to achieve near-normal basal glucose control in pump-treated type 2 diabetes.
King AB; Clark D; Wolfe GS
Diabetes Technol Ther; 2012 Oct; 14(10):900-3. PubMed ID: 22845649
[TBL] [Abstract][Full Text] [Related]
5. Development of optimal kids insulin dosing system formulas for young children with type 1 diabetes mellitus.
Alemzadeh R; Hoffmann RG; Dasgupta M; Parton E
Diabetes Technol Ther; 2012 May; 14(5):418-22. PubMed ID: 22239470
[TBL] [Abstract][Full Text] [Related]
6. Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.
Kuroda A; Yasuda T; Takahara M; Sakamoto F; Kasami R; Miyashita K; Yoshida S; Kondo E; Aihara K; Endo I; Matsuoka TA; Kaneto H; Matsumoto T; Shimomura I; Matsuhisa M
Diabetes Technol Ther; 2012 Nov; 14(11):1077-80. PubMed ID: 23101953
[TBL] [Abstract][Full Text] [Related]
7. Minimal reduction in insulin dosage with pramlintide therapy when pretreatment near-normal glycemia is established and square-wave meal bolus is used.
King AB
Endocr Pract; 2009 Apr; 15(3):229-33. PubMed ID: 19364691
[TBL] [Abstract][Full Text] [Related]
8. Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio.
Davidson PC; Hebblewhite HR; Steed RD; Bode BW
Endocr Pract; 2008 Dec; 14(9):1095-101. PubMed ID: 19158048
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
Henry RR; Dandona P; Pettus J; Mudaliar S; Xu J; Hansen L
Diabetes Obes Metab; 2017 Jun; 19(6):814-821. PubMed ID: 28098426
[TBL] [Abstract][Full Text] [Related]
10. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels.
Walsh J; Roberts R; Bailey T
J Diabetes Sci Technol; 2010 Sep; 4(5):1174-81. PubMed ID: 20920437
[TBL] [Abstract][Full Text] [Related]
13. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians.
Nimri R; Dassau E; Segall T; Muller I; Bratina N; Kordonouri O; Bello R; Biester T; Dovc K; Tenenbaum A; Brener A; Šimunović M; Sakka SD; Nevo Shenker M; Passone CG; Rutigliano I; Tinti D; Bonura C; Caiulo S; Ruszala A; Piccini B; Giri D; Stein R; Rabbone I; Bruzzi P; Omladič JŠ; Steele C; Beccuti G; Yackobovitch-Gavan M; Battelino T; Danne T; Atlas E; Phillip M
Diabetes Obes Metab; 2018 Oct; 20(10):2458-2466. PubMed ID: 29885025
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of insulin-to-carbohydrate ratio in children and adolescents with type 1 diabetes using multiple daily injection therapy.
Hegab AM
Pediatr Diabetes; 2019 Dec; 20(8):1087-1093. PubMed ID: 31433557
[TBL] [Abstract][Full Text] [Related]
15. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
Pettus J; Edelman SV
Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
[TBL] [Abstract][Full Text] [Related]
16. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
[TBL] [Abstract][Full Text] [Related]
17. Bolus Calculator Settings in Well-Controlled Prepubertal Children Using Insulin Pumps Are Characterized by Low Insulin to Carbohydrate Ratios and Short Duration of Insulin Action Time.
Hanas R; Adolfsson P
J Diabetes Sci Technol; 2017 Mar; 11(2):247-252. PubMed ID: 27470666
[TBL] [Abstract][Full Text] [Related]
18. A Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 Diabetes.
King AB; Kuroda A; Matsuhisa M; Hobbs T
Curr Diab Rep; 2016 Sep; 16(9):83. PubMed ID: 27457238
[TBL] [Abstract][Full Text] [Related]
19. HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS.
Pettus J; Price DA; Edelman SV
Endocr Pract; 2015 Jun; 21(6):613-20. PubMed ID: 25716635
[TBL] [Abstract][Full Text] [Related]
20. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
